Primary hyperhidrosis in children: A review of therapeutics

Courtney Remington1, Jennifer Ruth2,3, Adelaide A Hebert4

  • 1The University of Texas Rio Grande Valley School of Medicine, Edinburg, TX, USA.

Pediatric Dermatology
|March 4, 2021
PubMed

Insights

Primary hyperhidrosis causes excessive sweating in children and teens, impacting well-being. This review covers current and emerging treatments for this common condition.

Area of Science:

  • Dermatology
  • Pediatrics

Background:

  • Primary hyperhidrosis is a condition causing excessive sweating beyond physiological needs.
  • It typically begins in childhood or adolescence, affecting quality of life.

Purpose of the Study:

  • To review current therapeutic options for primary hyperhidrosis in pediatric patients.
  • To identify emerging treatments and research needs for this condition.

Main Methods:

  • Literature review of existing therapeutic options.
  • Exploration of topical, oral, procedural, and adjunctive therapies.
  • Identification of novel and developing treatment strategies.

Main Results:

  • Various treatment modalities exist for pediatric primary hyperhidrosis.
  • New and emerging treatments show promise for managing the condition.
  • Further research is needed to expand therapeutic options.

Conclusions:

  • Effective management strategies for pediatric primary hyperhidrosis are available.
  • Ongoing research and development are crucial for improving patient outcomes.
  • Addressing the multifaceted impact of hyperhidrosis on well-being is essential.

Related Concept Videos

Accessory Structures of the Skin: Sweat Glands01:20

Accessory Structures of the Skin: Sweat Glands

Sweat glands or sudoriferous glands are one of the important accessory structures of the skin. They are small, coiled tubular structures located in the dermis, the middle layer of the skin. Sweat glands are responsible for producing and secreting sweat, a watery fluid that helps regulate body temperature and excrete waste products.
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
87
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
101
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
95
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.3K